Managing Data and Providing Competitive Insights from Clinical Trials Using BizInt Smart Charts
|
|
|
- Alexis Carson
- 10 years ago
- Views:
Transcription
1 Managing Data and Providing Competitive Insights from Clinical Trials Using BizInt Smart Charts Pharma-Bio-Med Venice, Italy 21 Nov 2011 Diane Webb, President, BizInt Solutions Jennifer Friend-Huizer, Manager, Global Business Intelligence, Janssen Global Services (J&J) 2011 BizInt Solutions, Inc. 1
2 Goals for this presentation Conduct a case study of trials for two drugs using three clinical trials databases. Evaluate using tools in BizInt Smart Charts. Discuss how clinical trials databases are used for competitive intelligence. Slides will be at News & Events Presentations 2011 BizInt Solutions, Inc. 2
3 Case study - methodology Searched three clinical trials databases: ClinicalTrials.gov (CT.gov) Citeline TrialTrove (TT) Adis Clinical Trials Insight (CTI) Searches performed in April, July, Sept 2011 Searched two compounds: Januvia (diabetes, launched,) Teleprevir (hepatitis-c, late phase 3/launched) 2011 BizInt Solutions, Inc. 3
4 Januvia Search Methodology Januvia search methodology 2011 BizInt Solutions, Inc. 4
5 Telaprevir Search Methodology Telaprevir search methodology 2011 BizInt Solutions, Inc. 5
6 Clinical Trial Databases - Strengths Strength Adis CTI TrialTrove CT.gov Additional research support Full indication coverage limited Mechanism of Action search Results and Links to completed trial details Trial Alerts/Saved Searches Comprehensive advanced searching Only if in text (ROA, Endpoints, Dose, Formulation, etc) (some) 2011 BizInt Solutions, Inc. 6
7 Case study search results Januvia April 2011 July 2011 Sept 2011 CT.gov 202 trials 221 trials 223 trials Citeline TT 276 trials 303 trials 311 trials Adis CTI 219 trials 257 trials 280 trials Teleprevir April 2011 July 2011 Sept 2011 CT.gov 36 trials 37 trials 38 trials Citeline TT 45 trials 48 trials 65 trials Adis CTI 37 trials 42 trials 43 trials 2011 BizInt Solutions, Inc. 7
8 Case study Common Trial ID tool 2011 BizInt Solutions, Inc. 8
9 Case study Common Trial ID tool 2011 BizInt Solutions, Inc. 9
10 Case study Statistics Why so many records associated with a single trial? 2011 BizInt Solutions, Inc. 10
11 Case study Common Trial ID tool Incorrect VX trial ID results in two trials being grouped in error BizInt Solutions, Inc. 11
12 Case study Common Trial ID tool Phase IV trial ID included for all prior related trials BizInt Solutions, Inc. 12
13 Januvia Overlap between databases ClinicalTrials.gov (NCT) 49% of unique trials found in all 3 databases Citeline Trialtrove (TT) Adis Clinical Trials Insight (CTI) 2011 BizInt Solutions, Inc. 13
14 Januvia trials Database coverage Citeline TrialTrove 83% Clinical Trials.gov 59% Percentage of unique trials retrieved from each database. Adis Clinical Trials Insight 75% 49% of unique trials found in all 3 databases BizInt Solutions, Inc. 14
15 Januvia evaluation 117 trials appear from a single database (72-TT, 37-CTI, 9-CT.gov) Many trials that were found in only TT or CTI were from conference abstracts. Several trials from only TT or TT/CTI were sourced from UMIN-CTR Clinical Trials (Japanese clinical trial registry for non-profit trials (not industry sponsored). CT.gov does not appear to pick these up. Review of a single trial from Adis that included an NCT number showed no instance of sitagliptin in the CT.gov record that was reviewed BizInt Solutions, Inc. 15
16 Januvia evaluation (cont.) Of the 9 trials found only CT.gov, 2 did not have Januvia in the record. The 7 others are legitimate trials but were not retrieved from TT or CTI. One trial only in Adis was a new observational trial of 500 patients in Japan source from University Hospital Medical Information Network - Japan. One trial only in TT contained a record from 2009 where it was sourced from the ADA conference BizInt Solutions, Inc. 16
17 Telaprevir Database coverage Citeline TrialTrove 92% Percentage of unique trials retrieved from each database. Adis CTI 61% Clinical Trials.gov 54% 52% of unique trials found in all 3 databases BizInt Solutions, Inc. 17
18 Telaprevir some evaluation 33 trials appear from a single database (28-TT, 5-CTI, 0-CT.gov) Two single trials were matched as same trials from TT and Adis CTI by reviewing title, phase, subject number and drugs One of these trials was picked up by a conference abstract and not found in CT.gov Another trial was new in Adis CTI and updated in TT, but not in CT.gov 2011 BizInt Solutions, Inc. 18
19 Januvia: Competitive intelligence insights Review newly added trials What is the company currently working on? For Example review all company sponsored trials to look for new indications, post marketing trials, new patient populations. Review competitors that are doing head to head trials with drug. Of the 87 new trial records added in the July Update, 22 are sponsored by Merck BizInt Solutions, Inc. 19
20 Januvia: updating reports with change detection 2011 BizInt Solutions, Inc. 20
21 Januvia: highlighting trials of possible interest 2011 BizInt Solutions, Inc. 21
22 Januvia: Competitive intelligence insights Trial NCT is for a different patient population & indication -- NASH (Non-alcoholic Steatohepatitis) in Patients With Type 2 Diabetes. Trial started in December 2010 to be completed in 2013 Primary endpoint to improve liver disease by liver biopsy Small trial in Canada see if other trials with same patient population on larger scale. Not sponsored by Merck, so perhaps not looking at add-on indication 2011 BizInt Solutions, Inc. 22
23 Januvia how to deal with duplicate records? 2011 BizInt Solutions, Inc. 23
24 Januvia Reference Rows DB Rankings 2011 BizInt Solutions, Inc. 24
25 Januvia Reference Rows Column Rules 2011 BizInt Solutions, Inc. 25
26 Januvia Reference Rows 2011 BizInt Solutions, Inc. 26
27 Januvia - Reference Rows HTML report 2011 BizInt Solutions, Inc. 27
28 Reference Rows terminology variation 2011 BizInt Solutions, Inc. 28
29 XML Smart Data Exchange - normalization 2011 BizInt Solutions, Inc. 29
30 Reference Row HTML with normalized fields 2011 BizInt Solutions, Inc. 30
31 Intellixir analysis of trial locations (countries) 2011 BizInt Solutions, Inc. 31
32 Competitive Intelligence Must be Actionable! Clinical Trial intelligence adds an added level of focus to Pipeline Intelligence. Determine key competitor drug trial endpoints. Determine when trials may be ending to predict potential product launches. Monitor additional indications being sought. Determine in which countries trials are being run and for which indications. Evaluate dosing and delivery options BizInt Solutions, Inc. 32
33 Come to our table to learn more! Visit our exhibit to learn more Or visit BizInt Solutions, Inc. 33
The Problem: Challenges in Visualizing Pharmaceutical Business Information
Challenges in Visualizing Pharmaceutical Business Information II-SDV, Nice, France Diane Webb, President, BizInt Solutions Inc. The Problem: Visualizations developed for scientific and patent data do not
Driving Innovation in Licensing Through Competitive Intelligence and Big Data Analytics
Driving Innovation in Licensing Through Competitive Intelligence and Big Data Analytics John D Antonio Practice Leader, Licensing & Competitive Intelligence About Paragon We help increase asset value from
How To Use Data Analysis To Get More Information From A Computer Or Cell Phone To A Computer
Applying Big Data approaches to Competitive Intelligence challenges THOMSON REUTERS IP & SCIENCE PHARMA CI EUROPE CONFERENCE & EXHIBITION TIM MILLER 19 FEBRUARY 2014 BIG DATA, NOT JUST ABOUT VOLUMES Patient
Introduction to PatBase
Introduction to PatBase Overview A single, global patent family database Launched in October 2003 by Minesoft and RWS Group in partnership Worldwide representation including Europe, USA, Japan, China,
specify your database ranking; and create rules for each column specifying how data is chosen from related records;
Pharma-Bio-Med & BioSciences Conference and Exposition 2011 Programme Sunday 13, November Wednesday, 16 November Sunday, November 13, 2011 15:00-15:25 How Science Translational Medicine Accelerates Your
Europe Rheumatoid Arthritis Market Highlights - 2015
Brochure More information from http://www.researchandmarkets.com/reports/3447138/ Europe Rheumatoid Arthritis Market Highlights - 2015 Description: The latest research, 'Europe Rheumatoid Arthritis Market
Population Health for Pharma: Perspectives from Aetna/Healthagen
Population Health for Pharma: Perspectives from Aetna/Healthagen Van Crocker, President, Healthagen Outcomes April 2015 The future of healthcare depends on population health management Episodic treatment
PharmaPendium. The definitive source of best-in-class drug information
Please contact us for more information Americas E-Customer Service 360 Park Avenue South New York, NY 10010-1710 USA Tel: +1 888 615 4500 (+1 212 462 1978, if calling from outside the USA and Canada) Fax:
THOMSON REUTERS CORTELLIS FOR INFORMATICS. REUTERS/ Aly Song
THOMSON REUTERS CORTELLIS FOR INFORMATICS REUTERS/ Aly Song THOMSON REUTERS CORTELLIS FOR INFORMATICS 1 Table of Contents Table of Contents...1 The challenge... 2 The solution... 2 WHAT CAN YOU DO WITH
The Next Wave of Psoriasis Drug Programs: Targeting IL-17 and IL-23 PAMELA SPICER ANALYST, CNS, AUTOIMMUNE/INFLAMMATION, OPHTHALMOLOGY
The Next Wave of Psoriasis Drug Programs: Targeting IL-17 and IL-23 PAMELA SPICER ANALYST, CNS, AUTOIMMUNE/INFLAMMATION, OPHTHALMOLOGY 2 Psoriasis is a chronic inflammatory condition that primarily affects
Integration Set Up Guide
Integration Set Up Guide The Marketo Integration for Pipeliner CRM powered by itduzzit makes it possible to automatically create or update Leads and Contacts directly in Pipeliner CRM. Get started now:
Phase 2 Incident Reporting Management System (IRMS) Associate Technician Level Access
Phase 2 Incident Reporting Management System (IRMS) Associate Technician Level Access The Incident Report Management System (IRMS) provides 24/7 access and allows the NEC Associate technician to create
Singapore Clinical Trials Register. Foo Yang Tong Director Clinical Trials Branch Health Products Regulation Group HEALTH SCIENCES AUTHORITY
Singapore Clinical Trials Register Foo Yang Tong Director Clinical Trials Branch Health Products Regulation Group HEALTH SCIENCES AUTHORITY Clinical Trial Register Global Trend EMA: EU Clinical Trials
Multiple Sclerosis. Current and Future Players. GDHC1009FPR/ Published March 2013
Multiple Sclerosis Current and Future Players GDHC1009FPR/ Published March 2013 Executive Summary Moderate Growth in the Multiple Sclerosis Market is Expected from 2012 2022 GlobalData estimates the 2012
REFERENCE CODE GDHC269DFR PUBLICATION DATE JULY 2013 PREMARIN (POSTMENOPAUSAL VAGINAL ATROPHY) - FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC269DFR PUBLICATION DATE JULY 2013 PREMARIN Executive Summary Premarin (conjugated estrogen cream): Key Metrics in the Seven Major Pharmaceutical Markets 2012 Market Sales US 5EU Japan
Index. Registry Report
2013.1-12 Registry Report 01 02 03 06 19 21 22 23 24 25 26 27 28 29 31 34 35 Index Registry Report 02 Registry Report Registry Report 03 04 Registry Report Registry Report 05 06 Registry Report Registry
The Japan Society of Mechanical Engineers C 2010
The Japan Society of Mechanical Engineers C 2010 The Japan Society of Mechanical Engineers 2010 C The Japan Society of Mechanical Engineers 2010 C The Japan Society of Mechanical Engineers C 2010 The Japan
Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009
Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009 The innovative pharmaceutical industry 2 is committed to the transparency
BRISTOL-MYERS SQUIBB DATA DISCLOSURE & TRANSPARENCY
BRISTOL-MYERS SQUIBB DATA DISCLOSURE & TRANSPARENCY TRUSTED COMPANY Since 2001, Sylogent systems have been utilized by leading BioPharma companies Publication Planning Data Disclosure & Transparency Study
Normand Laberge Vice-President Regulatory & Scientific Affairs Rx&D. Globalization of Clinical Research: Trends & Implications for Canada
Normand Laberge Vice-President Regulatory & Scientific Affairs Rx&D Globalization of Clinical Research: Trends & Implications for Success Rates by Phase and Therapeutic Area Source: Nature Reviews Drug
PHARMACEUTICAL BIGDATA ANALYTICS
PHARMACEUTICAL BIGDATA ANALYTICS ANDINSIGHTS December 2013 Strategic Research Insights, Inc. 2013 Sources of Big Data in rpharmaceutical and Healthcare Industry Challenges with Big Data in Pharma Oncology
Q3 2015 Financial Results and Corporate Update. November 4, 2015
Q3 2015 Financial Results and Corporate Update November 4, 2015 Introductions and Forward- Looking Statements Silvia Taylor, SVP Investor Relations and Corporate Affairs Agenda Introductions and Forward-Looking
Welcome to the course on the Bank Statement Processing setup. 2-1
Welcome to the course on the Bank Statement Processing setup. 2-1 In this topic, we install the Bank Statement Processing. We also configure the initial settings for the Bank Statement Processing. 2-2
NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum
OVERVIEW OF THE FELLOWSHIP The goal of the AASLD NP/PA Fellowship is to provide a 1-year postgraduate hepatology training program for nurse practitioners and physician assistants in a clinical outpatient
Global Opioid Dependence Drugs Market Highlights - 2015
Brochure More information from http://www.researchandmarkets.com/reports/3293542/ Global Opioid Dependence Drugs Market Highlights - 2015 Description: The latest research Global Opioid Dependence Drugs
Efficacy, safety and preference study of a insulin pen PDS290 vs. a Novo Nordisk marketed insulin pen in diabetics
Efficacy, safety and preference study of a insulin pen PDS290 vs. a Novo Nordisk marketed insulin pen in diabetics This trial is conducted in the United States of America (USA). The aim of this clinical
HEALTHCARE SYSTEMS: A COMPARISON OF CANADA, THE UNITED KINGDOM, AND THE UNITED STATES Research Report for WR227 Sum Won Yu Noh Fall Term, 2013
HEALTHCARE SYSTEMS: A COMPARISON OF CANADA, THE UNITED KINGDOM, AND THE UNITED STATES Research Report for WR227 Sum Won Yu Noh Fall Term, 2013 1 Table of Contents Table of Contents...2 Introduction...3
Novel therapeutic approaches in multiple sclerosis Neuroprotective and remyelinating agents, the future of clinical trials in MS?
Novel therapeutic approaches in multiple sclerosis Neuroprotective and remyelinating agents, the future of clinical trials in MS? Marie Trad, M.D., Lynne Hughes, Cathy VanBelle, Amy Del Medico 3rd International
Span Global Services Marketing and Data Management Solutions
Span Global Services and Data Management Solutions Customer Acquisition Customer Retention Customer Loyalty A Compete Package of Data Management products from Span Global Services Call Us: 877-837-4884
Clinical Trials Reporting Program (CTRP) and Clinicaltrials.gov (CT.gov) Helpful tips and guidance
Clinical Trials Reporting Program (CTRP) and Clinicaltrials.gov (CT.gov) Helpful tips and guidance Objectives NCI s Clinical Trials Reporting Program (CTRP) Overview CTRP What is it? CTRP is an NCI mandated
SAS Enterprise Guide in Pharmaceutical Applications: Automated Analysis and Reporting Alex Dmitrienko, Ph.D., Eli Lilly and Company, Indianapolis, IN
Paper PH200 SAS Enterprise Guide in Pharmaceutical Applications: Automated Analysis and Reporting Alex Dmitrienko, Ph.D., Eli Lilly and Company, Indianapolis, IN ABSTRACT SAS Enterprise Guide is a member
Medicare Part D Plan Finder instructions
Medicare Part D Plan Finder instructions You can use these instructions to help you find the lowest cost Part D plans (both stand alone and Advantage plans) for the prescription drugs that you take. You
Non-Alcoholic Fatty Liver Disease
Non-Alcoholic Fatty Liver Disease Information for patients and families UHN Read this information to learn: what non-alcoholic fatty liver disease is what causes it how it s treated how to prevent it where
A How-to Guide for Trial Summary 3.1.3
A How-to Guide for Trial Summary 3.1.3 Nicola Tambascia & Anita Eisberg Accovion GmbH PhUSE SDE Frankfurt 2014 A How-to Guide for Trial Summary 3.1.3, May 6 th 2014, PhUSE SDE Frankfurt 1 Agenda CDISC
Chapter 8: Types of Business Process Outsourcing. Imtiaz Surve H. Surve
Chapter 8: Types of Business Process Outsourcing H. Surve 1 Coverage Types of Outsourcing Voice or Front-office Outsourcing Non-voice or Back-office Outsourcing Self Assessment 2 Types of Outsourcing 1.
Trial Description. Organizational Data. Secondary IDs
Trial Description Title A randomized, double-blind, multicenter study to demonstrate equivalent efficacy and to compare safety and immunogenicity of a biosimilar etanercept (GP2015) and Enbrel in patients
Business Development & Licensing Journal For the Pharmaceutical Licensing Groups
www.plg-uk.com Business Development & Licensing Journal For the Pharmaceutical Licensing Groups Consolidation in the generics sector Integrating business development Cross-cultural negotiations Self-reporting
SEO 2.0 ADVANCED SEO TIPS & TECHNIQUES ABSTRACT»
2.0 ADVANCED TIPS & TECHNIQUES ABSTRACT» Savvy online marketers know that their website is a great tool for branding, content promotion and demand generation. And they realize that search engine optimization
Managing Identities and Admin Access
CHAPTER 4 This chapter describes how Cisco Identity Services Engine (ISE) manages its network identities and access to its resources using role-based access control policies, permissions, and settings.
Basic Results Database
Basic Results Database Deborah A. Zarin, M.D. ClinicalTrials.gov December 2008 1 ClinicalTrials.gov Overview and PL 110-85 Requirements Module 1 2 Levels of Transparency Prospective Clinical Trials Registry
In this presentation, you will be introduced to data mining and the relationship with meaningful use.
In this presentation, you will be introduced to data mining and the relationship with meaningful use. Data mining refers to the art and science of intelligent data analysis. It is the application of machine
Automated press clipping with professional editing
www.cyberalert.com Nobody Monitors The Media Better CyberAlert, Inc., Foot of Broad St., Stratford, CT 06615 Phone: 203-375-7200 Fax: 203-375-6699 Toll Free: 1-800-461-7353 [email protected] Product
Strategy Formulation in Japanese Management
Strategy Formulation in Japanese Management Copyright 2007 Keio University Quote of the Day Cheshire Puss, she (Alice) began would you tell me, please, which way to got from there? That depends a good
How To Create Employee Review Documents In Peoplesoft
PeopleSoft HR 9.1 PeopleBook: Manage Employee Reviews March 2012 PeopleSoft HR 9.1 PeopleBook: Manage Employee Reviews SKU hcm91fp2herv-b0312 Copyright 1988, 2012, Oracle and/or its affiliates. All rights
Your Pharmacy Benefit: Make it Work for You!
Your Pharmacy Benefit: Make it Work for You! www.yourpharmacybenefit.org Table of Contents Choose Your Plan.............................................2 Steps in Choosing Your Pharmacy Benefits.........................
Medical Equipment Monthly Deals Analysis: January 2015- M&A and Investment Trends
Medical Equipment Monthly Deals Analysis: January 2015- M&A and Investment Trends Reference Code: GDME0470MD Publication Date: March 2015 Independent Medical Equipment Research M&A Trends and Analysis
NAACCR 2015 Annual Conference Sandy Jones June 18, 2015
USE OF INTEGRATING THE HEALTHCARE ENTERPRISE (IHE) STANDARDIZED DATA CAPTURE (SDC) CONTENT PROFILE TO EXCHANGE STANDARDIZED DATA BETWEEN CLINICAL CARE AND CANCER REGISTRIES NAACCR 2015 Annual Conference
Global Alzheimer s Platform. Luc Truyen, [email protected] George Vradenburg, [email protected] Debra Lappin, debra.lappin@faegrebd.
Global Alzheimer s Platform 2015 Luc Truyen, [email protected] George Vradenburg, [email protected] Debra Lappin, [email protected] 1 Presentation 1. Today s Reality 2. Global Momentum 3. GAP
SAMPLE. Asia-Pacific Interventional Cardiology Procedures Outlook to 2020. Reference Code: GDMECR0061PDB. Publication Date: May 2014
Asia-Pacific Interventional Cardiology Procedures Outlook to 2020 Reference Code: GDMECR0061PDB Publication Date: May 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2
NEXT Analytics Business Intelligence User Guide
NEXT Analytics Business Intelligence User Guide This document provides an overview of the powerful business intelligence functions embedded in NEXT Analytics v5. These functions let you build more useful
Big Data in Healthcare: Current Possibilities and Emerging Opportunities
Big Data in Healthcare: Current Possibilities and Emerging Opportunities Andrew Bate Senior Director, Epidemiology Group Lead, Analytics 23 th March 2015 The Long Road In Developing a New Medicine Clinical
SAMPLE QUESTIONS EXAM EXEMPLAR QUESTIONS. D5 - Managing contracts and relationships in procurement and supply
Level 4 Diploma in Procurement and Supply D5 - Managing contracts and relationships in procurement and supply EXAM EXEMPLAR QUESTIONS QUESTIONS AND INDICATIVE ANSWER CONTENT Page 1 of 6 QUALIFICATIONS
Keys to success in multi-channel marketing in Japan
Keys to success in multi-channel marketing in Japan Abstract In the US and Europe, we have seen a drastic decline in the number of MRs and a rapid shift towards non-traditional multi-channel marketing
An Introduction to Using CINAHL
An Introduction to Using CINAHL Through EBSCOhost What is CINAHL? CINAHL stands for the Cumulative Index of Nursing and Allied Health Literature and is the largest and most in-depth nursing research database.
Coverage Analysis: The Cornerstone of Clinical Research Billing Presented by: Mary L. Veazie, CPA, MBA, CHC, CHRC Executive Director, Clinical
Coverage Analysis: The Cornerstone of Clinical Research Billing Presented by: Mary L. Veazie, CPA, MBA, CHC, CHRC Executive Director, Clinical Research Finance The University of Texas MD Anderson Cancer
Data Warehouse and Business Intelligence Testing: Challenges, Best Practices & the Solution
Warehouse and Business Intelligence : Challenges, Best Practices & the Solution Prepared by datagaps http://www.datagaps.com http://www.youtube.com/datagaps http://www.twitter.com/datagaps Contact [email protected]
Asian Data Resources. October 24, 2014 8:30-12:30 Using pharmacoepidemiology database resources to address drug safety research
Draft Asian Data Resources October 24, 2014 8:30-12:30 Using pharmacoepidemiology database resources to address drug safety research Kiyoshi Kubota MD PhD FISPE NPO Drug Safety Research Unit Japan Multiple
Leads Best Practice: Lead Generation, Management & Performance
Leads Best Practice: Lead Generation, Management & Performance Best Practice: Leads Business Driver Best Practice Overview Best Practice: Leads Marketing Effectiveness Lead Generation and Integration Lead
Richard T. Clark Chief Executive Officer and President. Executing on Our Strategy
Richard T. Clark Chief Executive Officer and President Executing on Our Strategy Merck s Plan to Win: Preparing for Our Future Success BECOME THE MOST TRUSTED INDUSTRY LEADER IN DELIVERING VALUE TO CUSTOMERS
Strategic Consulting Services
Services 1 Leadership Team Mark Levonyak President [email protected] Mobile: 214.460.5051 Martin W. Lee, MD EVP, Clinical Trial Services [email protected] Mobile: 952.373.1405 John Eckardt, MD Chief
Xarelto (Atrial Fibrillation) - Analysis and Forecasts to 2022
Brochure More information from http://www.researchandmarkets.com/reports/2152222/ Xarelto (Atrial Fibrillation) - Analysis and Forecasts to 2022 Description: Xarelto (Atrial Fibrillation) Analysis and
CHAPTER 5: BUSINESS ANALYTICS
Chapter 5: Business Analytics CHAPTER 5: BUSINESS ANALYTICS Objectives The objectives are: Describe Business Analytics. Explain the terminology associated with Business Analytics. Describe the data warehouse
Clinical Trial Transparency. What is available?
Clinical Trial Transparency What is available? 1 Outline Clinical Trial Data Collection and Reporting Data Definitions Clinical Trial Transparency Summary Report Requirements Example of Results Posting
Chapter 2. Analyzing transactions
1 Chapter 2 Analyzing transactions 2 Learning objectives 1. Explain the steps in the accounting cycle and each step s supporting documentation 2. Explain the purpose of source documents 3. Describe an
Risk-sharing Agreements: Country Experiences and Challenges
Risk-sharing Agreements: Country Experiences and Challenges 101/2014 INSEAD Healthcare Management Initiative www.insead.edu/hmi [email protected] Written by Ridhima Aggarwal, The Salmon and Rameau Research
Breakthrough Therapy Program U.S. Food and Drug Administration (FDA)
Breakthrough Therapy Program U.S. Food and Drug Administration (FDA) Presentation before the European Commission Expert Group on Safe and Timely Access to Medicines for Patients (STAMP) Jarilyn Dupont,
Global Pharmaceuticals Marketing Channel Reference EDITION
Global Pharmaceuticals Marketing Channel Reference EDITION 2015 ABOUT IMS HEALTH IMS Health is a leading global information and technology services company providing clients in the healthcare industry
Instructions of ClinicalTrials.gov Protocol Registration
Instructions of ClinicalTrials.gov Protocol Registration STEP I: Getting Started 1. Create an account: contact RU ClinicalTrials.gov Protocol Registration System (PRS) Administrator Rebecca Chen (973-972.1149
Yamanouchi and Fujisawa Enter into A Basic Agreement to Merge on April 1, 2005
February 24, 2004 Yamanouchi and Fujisawa Enter into A Basic Agreement to Merge on April 1, 2005 Yamanouchi Pharmaceutical Co., Ltd. (Headquartered in Tokyo, Japan; President and CEO: Toichi Takenaka,
Release 2.1 of SAS Add-In for Microsoft Office Bringing Microsoft PowerPoint into the Mix ABSTRACT INTRODUCTION Data Access
Release 2.1 of SAS Add-In for Microsoft Office Bringing Microsoft PowerPoint into the Mix Jennifer Clegg, SAS Institute Inc., Cary, NC Eric Hill, SAS Institute Inc., Cary, NC ABSTRACT Release 2.1 of SAS
Converting an Excel Spreadsheet Into an Access Database
Converting an Excel Spreadsheet Into an Access Database Tracey L. Fisher Personal Computer and Software Instructor Butler County Community College - Adult and Community Education Exceeding Your Expectations..
NIH Research Performance Progress Reports (RPPR)
NIH Research Performance Progress Reports (RPPR) Helpful Hints for the UW Research Community This document is meant as a tool for research administrators to collect information from PIs for the new RPPR
Introduction to Incident Reporting Management System (IRMS) Associate Management Level Access Phase 2
Introduction to Incident Reporting Management System (IRMS) Associate Management Level Access Phase 2 The Incident Report Management System (IRMS) provides 24/7 access and allows the NEC Associate technician
Pharmaceutical Risk Sharing Agreements C. Bernie Good MD MPH Department of Veterans Affairs June 2014
Pharmaceutical Risk Sharing Agreements C. Bernie Good MD MPH Department of Veterans Affairs June 2014 Objectives Describe concept of Risk-Share Agreements Describe types of agreements Identify specific
Understanding Diseases and Treatments with Canadian Real-world Evidence
Understanding Diseases and Treatments with Canadian Real-world Evidence Real-World Evidence for Successful Market Access WHITEPAPER REAL-WORLD EVIDENCE Generating real-world evidence requires the right
Brochure More information from http://www.researchandmarkets.com/reports/3503782/
Brochure More information from http://www.researchandmarkets.com/reports/3503782/ Non-Alcoholic SteatoHepatitis (NASH): An Analysis of Disease Prevalence, Drugs in Development, Regulatory Guidelines and
FileNet P8 Platform Directory Service Migration Guide
FileNet P8 Platform Directory Service Migration Guide Release 3.5.1 November 2005 FileNet is a registered trademark of FileNet Corporation. All other product and brand names are trademarks or registered
Overview of CDISC Implementation at PMDA. Yuki Ando Senior Scientist for Biostatistics Pharmaceuticals and Medical Devices Agency (PMDA)
Overview of CDISC Implementation at PMDA Yuki Ando Senior Scientist for Biostatistics Pharmaceuticals and Medical Devices Agency (PMDA) CDISC 2012 Outline Introduction Update of PMDA activity CDISC implementation
CPOE Medication Order Entry
Ordering Specific Medications Any medication can be ordered individually. These can be searched by either the brand or generic name. NOTE: The search field setting of either starts with or contains can
Collections Reporting Web Topics:
Slide 1 Collections Reporting Web Topics: Using the Fedwire Download Report January 2013 Hello and welcome to this Web Topic on collections reporting. In this session, we will discuss the Fedwire Download
A Phase 2 Study of Interferon Beta-1a (Avonex ) in Ulcerative Colitis
A Phase 2 Study of (Avonex ) in Ulcerative Colitis - Study Results - ClinicalTrials.gov A Phase 2 Study of (Avonex ) in Ulcerative Colitis This study has been completed. Sponsor: Biogen Idec Information
CRM for Customer Service and Support
CRM for Customer Service and Support Maximize satisfaction. Drive repeat business Servicing customers effectively is a key component in growing your business through loyal, repeat buyers. Whether it s
